CDK8/19-IN-3

CAT: 0804-HY-168846Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-168846Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK8/19-IN-3 (compound 3-7) is a potent and selective CDK8 and CDK19 inhibitor. CDK8/19-IN-3 upregulates IL-10 levels. CDK8/19-IN-3 has the potential for the research of inflammatory bowel disease (IBD) [1].
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Inflammation/Immunology
Smiles
N#CC1=CC(C(N2C[C@@H](C3=NC(N4C[C@H](F)CC4)=NC=C3)C[C@@H](OC)C2)=O)=CN1
Molecular Formula
C20H23FN6O2
Molecular Weight
398.43
References & Citations
[1]Nicolle S, et al. Phenotype-Led Identification of IL-10 Upregulators in Human CD4+ T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors. J Med Chem. 2025 Jan 8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK19; CDK8

Related Products

CatalogName
HY-176282CDK8-IN-19
HY-158377CDK8/19-IN-2
HY-111427-01CDK8/19-IN-1
HY-111463-01CDK8-IN-3
HY-147716CDK8-IN-6
HY-151463-01CDK8-IN-11
HY-103492-01CDK8-IN-1
HY-171174-01CDK8-IN-16
HY-162600CDK8-IN-15
HY-169541CDK8-IN-18

Alternative Products

CatalogName
MF-0113440-01CDK8/19-IN-3
MF-0117843-01CDK8-IN-19
BUP21189-01CDK8/19-IN-51
MF-0004902-01CDK8/19-IN-1
MF-0148017-01CDK8/19-IN-2
A19986-100CDK8/19-IN-1 100mg
A19857-1Anti-CDK8/19 Antibody
A19986-1CDK8/19-IN-1 1mg
A19986-10CDK8/19-IN-1 10mg
A19986-25CDK8/19-IN-1 25mg

Popular Products